Johnson Elizabeth A, Oldfield Sue, Braksator Ellen, Gonzalez-Cuello Ana, Couch Daniel, Hall Kellie J, Mundell Stuart J, Bailey Chris P, Kelly Eamonn, Henderson Graeme
Department of Pharmacology, University of Bristol, Bristol, BS8 1TD, UK.
Mol Pharmacol. 2006 Aug;70(2):676-85. doi: 10.1124/mol.106.022376. Epub 2006 May 8.
The ability of two opioid agonists, [d-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin (DAMGO) and morphine, to induce mu-opioid receptor (MOR) phosphorylation, desensitization, and internalization was examined in human embryonic kidney (HEK) 293 cells expressing rat MOR1 as well G protein-coupled inwardly rectifying potassium channel (GIRK) channel subunits. Both DAMGO and morphine activated GIRK currents, but the maximum response to DAMGO was greater than that of morphine, indicating that morphine is a partial agonist. The responses to DAMGO and morphine desensitized rapidly in the presence of either drug. Expression of a dominant negative mutant G protein-coupled receptor kinase 2 (GRK2), GRK2-K220R, markedly attenuated the DAMGO-induced desensitization of MOR1, but it had no effect on morphine-induced MOR1 desensitization. In contrast, inhibition of protein kinase C (PKC) either by the PKC inhibitory peptide PKC (19-31) or staurosporine reduced MOR1 desensitization by morphine but not that induced by DAMGO. Morphine and DAMGO enhanced MOR1 phosphorylation over basal. The PKC inhibitor bisindolylmaleimide 1 (GF109203X) inhibited MOR1 phosphorylation under basal conditions and in the presence of morphine, but it did not inhibit DAMGO-induced phosphorylation. DAMGO induced arrestin-2 translocation to the plasma membrane and considerable MOR1 internalization, whereas morphine did not induce arrestin-2 translocation and induced very little MOR1 internalization. Thus, DAMGO and morphine each induce desensitization of MOR1 signaling in HEK293 cells but by different molecular mechanisms; DAMGO-induced desensitization is GRK2-dependent, whereas morphine-induced desensitization is in part PKC-dependent. MORs desensitized by DAMGO activation are then readily internalized by an arrestin-dependent mechanism, whereas those desensitized by morphine are not. These data suggest that opioid agonists induce different conformations of the MOR that are susceptible to different desensitizing and internalization processes.
在表达大鼠MOR1以及G蛋白偶联内向整流钾通道(GIRK)通道亚基的人胚肾(HEK)293细胞中,研究了两种阿片类激动剂,即[D - 丙氨酸(2),N - 甲基苯丙氨酸(4),甘氨酸(5) - 醇] - 脑啡肽(DAMGO)和吗啡,诱导μ-阿片受体(MOR)磷酸化、脱敏和内化的能力。DAMGO和吗啡均激活了GIRK电流,但DAMGO的最大反应大于吗啡,表明吗啡是部分激动剂。在任一药物存在下,对DAMGO和吗啡的反应迅速脱敏。显性负性突变体G蛋白偶联受体激酶2(GRK2),即GRK2 - K220R的表达,显著减弱了DAMGO诱导的MOR1脱敏,但对吗啡诱导的MOR1脱敏没有影响。相反,通过PKC抑制肽PKC(19 - 31)或星形孢菌素抑制蛋白激酶C(PKC)可降低吗啡诱导的MOR1脱敏,但不影响DAMGO诱导的脱敏。吗啡和DAMGO使MOR1磷酸化水平高于基础水平。PKC抑制剂双吲哚马来酰亚胺1(GF109203X)在基础条件下和吗啡存在时抑制MOR1磷酸化,但不抑制DAMGO诱导的磷酸化。DAMGO诱导抑制蛋白2易位至质膜并导致大量MOR1内化,而吗啡未诱导抑制蛋白2易位且仅诱导极少的MOR1内化。因此,DAMGO和吗啡均在HEK293细胞中诱导MOR1信号脱敏,但通过不同的分子机制;DAMGO诱导的脱敏依赖于GRK2,而吗啡诱导的脱敏部分依赖于PKC。被DAMGO激活而脱敏的MOR随后通过依赖于抑制蛋白的机制容易内化,而被吗啡脱敏的MOR则不然。这些数据表明,阿片类激动剂诱导MOR的不同构象,这些构象易受不同的脱敏和内化过程影响。